Buscar
01/05/2024
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting Response
Beato-Vibora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Gimenez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mira, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting Response. DIABETES CARE. 2024; 47(5)DOI:10.2337/dci24-0017. PMID:38640410. IF:16.600(Q1/1D).
01/05/2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
Garcia, MJ, Riestra, S, Amiot, A, Julsgaard, M, de la Filia, IG, Calafat, M, Aguas, M, de la Pena, L, Roig, C, Caballol, B, Casanova, MJ, Farkas, K, Boysen, T, Bujanda, L, Cuaran, C, Dobru, D, Fousekis, F, Gargallo-Puyuelo, CJ, Savarino, E, Calvet, X, Huguet, JM, Kupcinskas, L, López-Cardona, J, Raine, T, van Oostrom, J, Gisbert, JP, Chaparro, M. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 59(10)DOI:10.1111/apt.17938. PMID:38445785. IF:6.700(Q1/1D).
01/05/2024
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Gómez-Labrador, C, Ricart, E, Iborra, M, Iglesias, E, Martín-Arranz, MD, de Castro, L, De Francisco, R, García-Alonso, FJ, Sanahuja, A, Gargallo-Puyuelo, CJ, Mesonero, F, Casanova, MJ, Mañosa, M, Rivero, M, Calvo, M, Sierra-Ausin, M, González-Muñoza, C, Calvet, X, García-López, S, Guardiola, J, García, LA, Márquez-Mosquera, L, Gutiérrez, A, Zabana, Y, Navarro-Llavat, M, Poyatos, RL, Piqueras, M, Torrealba, L, Bermejo, F, Ponferrada-Díaz, A, Pérez-Calle, JL, Barreiro-de Acosta, M, Tejido, C, Cabriada, JL, Marín-Jiménez, I, Roncero, O, Ber, Y, Fernández-Salazar, L, Aler, BC, Lucendo, AJ, Llaó, J, Bujanda, L, Villafranca, CM, Domènech, E, Chaparro, M, Gisbert, JP. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA. Pharmaceutics. 2024; 16(5)DOI:10.3390/pharmaceutics16050629. PMID:38794292. IF:5.500(Q1/1D).
01/05/2024
Toxoplasma gondii in a Remote Subsistence Hunting-Based Indigenous Community of the Peruvian Amazon
Menajovsky, MF, Espunyes, J, Ulloa, G, Calderon, M, Diestra, A, Malaga, E, Muñoz, C, Montero, S, Lescano, AG, Santolalla, ML, Cabezón, O, Mayor, P. Toxoplasma gondii in a Remote Subsistence Hunting-Based Indigenous Community of the Peruvian Amazon. Tropical Medicine and Infectious Disease. 2024; 9(5)DOI:10.3390/tropicalmed9050098. PMID:38787031. IF:2.600(Q1/1D).
01/05/2024
Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual risk
Santos, CS, Oliveira, MM, Solari, PN, Mateus, P, Santos, MJ, Corominas, H, Castro, CA, Alvarez, ED. Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual risk. Reumatologia Clinica. 2024; 20(5)DOI:10.1016/j.reuma.2024.01.002. PMID:38880551. IF:(Q/D).
01/05/2024
Unraveling the Enigma: Spain Takes a Pioneering Step With REPAIR in the World of Inhaled Antibiotics
de la Rosa-Carrillo, D, Miravitlles, M, Pomares, X, Martínez-García, MA. Unraveling the Enigma: Spain Takes a Pioneering Step With REPAIR in the World of Inhaled Antibiotics. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(5)DOI:10.1016/j.arbres.2024.01.007. PMID:38310073. IF:9.200(Q1/1D).